Cargando…
In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression
Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068560/ https://www.ncbi.nlm.nih.gov/pubmed/29966381 http://dx.doi.org/10.3390/ijerph15071380 |
_version_ | 1783343297114144768 |
---|---|
author | Cho, Ching-Chang Hsieh, Wen-Yeh Tsai, Chin-Hung Chen, Cheng-Yi Chang, Hui-Fang Lin, Chih-Sheng |
author_facet | Cho, Ching-Chang Hsieh, Wen-Yeh Tsai, Chin-Hung Chen, Cheng-Yi Chang, Hui-Fang Lin, Chih-Sheng |
author_sort | Cho, Ching-Chang |
collection | PubMed |
description | Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components may also have different effects on people. The pathogenesis of PM(2.5) in several diseases remains to be clarified. There is a long history of epidemiological research on PM(2.5) in several diseases. Numerous studies show that PM(2.5) can induce a variety of chronic diseases, such as respiratory system damage, cardiovascular dysfunction, and diabetes mellitus. However, the epidemiological evidence associated with potential mechanisms in the progression of diseases need to be proved precisely through in vitro and in vivo investigations. Suggested mechanisms of PM(2.5) that lead to adverse effects and chronic diseases include increasing oxidative stress, inflammatory responses, and genotoxicity. The aim of this review is to provide a brief overview of in vitro and in vivo experimental studies of PM(2.5) in the progression of various diseases from the last decade. The summarized research results could provide clear information about the mechanisms and progression of PM(2.5)-induced disease. |
format | Online Article Text |
id | pubmed-6068560 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60685602018-08-07 In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression Cho, Ching-Chang Hsieh, Wen-Yeh Tsai, Chin-Hung Chen, Cheng-Yi Chang, Hui-Fang Lin, Chih-Sheng Int J Environ Res Public Health Review Air pollution is a very critical issue worldwide, particularly in developing countries. Particulate matter (PM) is a type of air pollution that comprises a heterogeneous mixture of different particle sizes and chemical compositions. There are various sources of fine PM (PM(2.5)), and the components may also have different effects on people. The pathogenesis of PM(2.5) in several diseases remains to be clarified. There is a long history of epidemiological research on PM(2.5) in several diseases. Numerous studies show that PM(2.5) can induce a variety of chronic diseases, such as respiratory system damage, cardiovascular dysfunction, and diabetes mellitus. However, the epidemiological evidence associated with potential mechanisms in the progression of diseases need to be proved precisely through in vitro and in vivo investigations. Suggested mechanisms of PM(2.5) that lead to adverse effects and chronic diseases include increasing oxidative stress, inflammatory responses, and genotoxicity. The aim of this review is to provide a brief overview of in vitro and in vivo experimental studies of PM(2.5) in the progression of various diseases from the last decade. The summarized research results could provide clear information about the mechanisms and progression of PM(2.5)-induced disease. MDPI 2018-07-01 2018-07 /pmc/articles/PMC6068560/ /pubmed/29966381 http://dx.doi.org/10.3390/ijerph15071380 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Cho, Ching-Chang Hsieh, Wen-Yeh Tsai, Chin-Hung Chen, Cheng-Yi Chang, Hui-Fang Lin, Chih-Sheng In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title | In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title_full | In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title_fullStr | In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title_full_unstemmed | In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title_short | In Vitro and In Vivo Experimental Studies of PM(2.5) on Disease Progression |
title_sort | in vitro and in vivo experimental studies of pm(2.5) on disease progression |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068560/ https://www.ncbi.nlm.nih.gov/pubmed/29966381 http://dx.doi.org/10.3390/ijerph15071380 |
work_keys_str_mv | AT chochingchang invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression AT hsiehwenyeh invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression AT tsaichinhung invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression AT chenchengyi invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression AT changhuifang invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression AT linchihsheng invitroandinvivoexperimentalstudiesofpm25ondiseaseprogression |